Closing prices at the end of each trading day, from 5 May 2025. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.
| FY2024 | FY2025 | |
|---|---|---|
| Operating income | −44.1 | −4.9 |
| Net income | −42.1 | −1.1 |
| Growth | ||
| EPS, diluted | −1.02 | −0.04 |
| Growth |
| FY2024 | FY2025 | |
|---|---|---|
| Operating cash flow | −10.3 | −12.8 |
| Capital expenditure | −0.6 | −0.5 |
| Free cash flow | −10.9 | −13.3 |
| Growth |
| FY2024 | FY2025 | |
|---|---|---|
| Cash and securities | 21.3 | 62.9 |
| Shareholders’ equity | 303.2 | 401.4 |
In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.
| Fiscal year | FY2024 31 Dec 2024 | FY2025 31 Dec 2025 |
|---|---|---|
| Operations | ||
| −10.3 | −12.8 | |
| Growth | ||
| Investment | ||
| −0.6 | −0.5 | |
| calc | −10.9 | −13.3 |
| Growth | ||
| calc | −0.23 | −0.26 |
| −32.0 | −21.0 | |
| Financing | ||
| 26.5 | 75.5 | |
Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative.